Inflammation: Mediators and Pathways reviews key developments in the field of inflammation. It focuses on novel pathways of inflammation that have only recently surfaced. All the topics covered are currently the subject of intense investigation, and all contributors are established investigators in the field.
Phospholipase A2 Isoforms as Novel Drug Targets, L.A. Marshall and R.J. MayerPharmacologic Regulation of Adhesion Molecule Function and Expression, R.S. Peebles, Jr., B.S. Bochner, and R.P. SchleimerPlatelet-Activating Factor (PAF) and Its Antagonists in Allergic and Inflammatory Disorders, E. Pirotzky, M. Koltai, D. Hosford, and P.G. BraquetThe Role of Eicosanoids in Transplant Rejection, R.F. Spurney and T.M. CoffmanPharmacology of CoA-Independent Transacylase, J.D. Winkler and F.H. ChiltonACAT Inhibitors: Physiologic Mechanisms for Hypolipidemic and Anti-Atherosclerotic Activities in Experimental Animals, B.R. Krause and T.M.A. Bocan